EIF4E and prostate carcinoma: Although the effect of eIF4E phosphorylation on its affinity for the cap remains the subject of research, phosphorylation of serine 209 has been linked with cell survival and proliferation in a number of cancers, including prostate cancer (32, 34, 51, 64, 65).